Anti-ERFE antibody (102-152 aa) (STJ193511)
SPECIFICATIONS
ClonalityPolyclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
ImmunogenSynthesized peptide derived from the human F132B at the amino acid range 102-152
General Information
| Short Description | Rabbit polyclonal anti-Erythroferrone (102-152 aa) for use in WB in Human and Mouse samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | WB |
| Host | Rabbit |
| Reactivity | Human/Mouse |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Concentration | 1 mg/mL |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Dilution Range | WB 1:500-2000 |
| Formulation | Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Storage Instruction | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Target Information
| Gene Symbol | ERFE |
| Gene ID | 151176 |
| Uniprot ID | ERFE_HUMAN |
| Immunogen | Synthesized peptide derived from the human F132B at the amino acid range 102-152 |
| Immunogen Region | 102-152 aa |
| Specificity | This antibody detects endogenous levels of F132B at Human/Mouse |
Additional Info
| Function | Iron-regulatory hormone that acts as an erythroid regulator after hemorrhage: produced by erythroblasts following blood loss and mediates suppression of hepcidin (HAMP) expression in the liver, thereby promoting increased iron absorption and mobilization from stores. Promotes lipid uptake into adipocytes and hepatocytes via transcriptional up-regulation of genes involved in fatty acid uptake. Inhibits apoptosis and inflammatory response in cardiomyocytes via promotion of sphingosine-1-phosphate (S1P) and cAMP-dependent activation of AKT signaling. Inhibits autophagy induced by nutrient deficiency in hepatocytes via promoting the phosphorylation of IRS1, AKT, and MTOR, and thereby subsequent activation of the AKT-MTOR signaling pathway. Negatively regulates the differentiation of osteoblasts, potentially via sequestering BMP2, and thereby inhibits the activation of SMAD signaling. The reduction in BMP2 signaling in osteoblasts also results in an increase in expression of the osteoclastogenesis-promoting factors TNFSF11/RANKL and SOST, thereby indirectly promotes bone resorption. |
| Protein Name | ErythroferroneComplement C1q Tumor Necrosis Factor-Related Protein 15Myonectin |
| Database Links | |
| Cellular Localisation | SecretedSecreted When Glycosylated At Asn-243 And Asn-295Hydroxylation Promotes Secretion |
| Alternative Antibody Names | Anti-Erythroferrone antibodyAnti-Complement C1q Tumor Necrosis Factor-Related Protein 15 antibodyAnti-Myonectin antibodyAnti-ERFE antibodyAnti-C1QTNF15 antibodyAnti-CTRP15 antibodyAnti-FAM132B antibody |
Information sourced from Uniprot.org